ABSTRACT Purified fibrinogen at concentrations of3-30 nM has been found to stimulate continuous growth ofhuman lymphoid and myeloid cell lines under serum-free conditions. A strong proliferative response resulted from the synergism elicited by the addition of fibrinogen to transferrin-supplemented medium. This effect was observed with the pre-B-cell line Raji, the T lymphomaderived JM, and the monocytic cell line U 937, either at high or low cell densities. With the promyelocytic cell line HL 60, fibrinogen did not shorten the doubling time of cultures seeded at high cell densities (2 x 105 cells per ml). However, at cell densities lower by 2 orders of magnitude and in the same medium, it promoted growth with a doubling time similar to that obtained at high cell concentrations. Fibrinogen also was found to increase the plating efficiency and colony size when human bone marrow cells were cultured in semisolid medium containing serum. In long-term bone marrow liquid cultures without fibrinogen, colony-forming cells were no longer detected after 6 weeks. In those cultured with fibrinogen, -50 granulocyte-macrophage colonies per 105 cells were obtained after 6 weeks, and 10, after 12 weeks. Purified fibrinogen fragment D possessed a stimulating activity similar to that of the intact fibrinogen molecule. This fragment cannot form fibrin, thus eliminating fibrin as a source of the mitogenic effect.
The use of serum in tissue culture hinders the study of the regulation of cellular proliferation (1) (2) (3) (4) (5) (6) because the roles and interactions amongst various growth factors are difficult to analyze in nondefined media. Sato and his group (for a review see ref. 7 ) have contributed to the development of the concept of hormonally defined media and have shown how useful these media can be for analyzing the controls of proliferation and differentiation at the molecular level. Iscove and co-workers (8) (9) (10) have applied this concept to the culture ofmurine hemopoietic cells.
A minimal medium is composed of defined factors that are all necessary in a particular combination for the growth of a particular cell type; removal ofeach factor individually prevents growth. These media facilitate the study of each growth requirement and its effects. By designing minimal media containing purified plasma components, we have analyzed their possible roles in the control of human hemopoietic cell proliferation (11) .
Fibrinogen is a major component of plasma, where its concentration is about 3 mg/ml. Blood clotting results from the polymerization of fibrinogen into fibrin (12) . Here we present evidence that fibrinogen may play another role by stimulating the proliferation of certain human hemopoietic cells.
MATERIALS AND METHODS
Reagents. Reagents were obtained from the following sources: thrombin from Roche; horse and fetal calf serum from Flow Laboratories; RPMI 1640, Iscove's modified Dulbecco's medium (IMD medium), stock solutions of L-glutamine (200 mM), penicillin/streptomycin at 10,000 units/ml and 10,000 pAg/ml, respectively, from GIBCO; and monoiodinated pig insulin from Commissariat Energie Atomique. Plasminogen and plasmin were prepared as described (13) . Other reagents were from Sigma.
Fibrinogen. Purified fibrinogen was provided by G. Marguerie. This material was more than 99% pure (14) . Pure fibrinogen fragments D and E were gifts from R. F. Doolittle.
Purified fibrinogen, mixed or not with radiolabeled insulin, was clotted by a 30-min treatment with thrombin (1 unit/ml), after which fibrin was extracted and washed with an equal volume ofsaline before being centrifuged on a Beckman Microfuge B, and the supernatant was collected.
Cell Lines. Raji, a pre-B-cell line (15) ; JM, derived from a human T-cell leukemia (16); U 937, a monocytic cell line (17) ; and K 562, an erythroid cell line (18) , were provided by G. Lenoir (International Agency for Research on Cancer, Lyon, France). HL 60, a promyelocytic cell line (19) , was provided by R. Gallo (National Cancer Institute, Bethesda, MD). Cell lines were maintained in suspension in RPMI 1640 medium with 2 g of sodium bicarbonate per liter, 1% penicillin/streptomycin and 1% L-glutamine stock solutions, and 10% heat-inactivated fetal calf serum in Coming TM 25 flasks. Defined media were prepared as described (11) . Doubling times were estimated only when cultures contained more than 98% viable cells as determined by trypan blue exclusion.
Long-Term Human Bone Marrow Culture and ColonyForming Cell Assays. Culture initiation was performed as described by Gartner and Kaplan (4) with the following exceptions. Growth medium consisted of IMD medium supplemented with 1 ,uM hydrocortisone, 15% fetal calf serum, 10% horse serum, 1% penicillin/streptomycin and 1% L-glutamine stock solutions, 10 nM transferrin, 50 ,uM 2-mercaptoethanol, and 3 g of sodium bicarbonate per liter. After 2 weeks, when stromal cells were established, fetal calf serum was reduced to 10% and hydrocortisone was reduced to 0.1 ,uM. Every week 5 ml of'culture was replaced with fresh medium. Colony-forming cells were cultured in medium containing methylcellulose as described by Messner and Fauser (1) .
RESULTS
Effect of Fibrinogen on Growth in Minimal Media. T and B lymphoid cell lines were studied for their response to fibrinogen in minimal media.
JM cell line. This cell line was derived from a human T lymphoma (16 (Fig. 1) .
When cells were seeded in IMD medium supplemented with transferrin at low density (i.e., 2 x 103 instead of2 x 105 cells per ml), no growth occurred. However, iffibrinogen was added at 10 j.g/ml, all of the single cells started to grow and formed clones, which could be isolated and expanded for continuous growth in this medium. Therefore IMD medium supplemented with transferrin and fibrinogen constitutes a minimal medium for growth of the JM cell line at low cell density.
In low cell density cultures, no stimulating cell contacts occur (20) and diffusible factors, such as T-cell growth factor (21), produced by the cells are diluted. Such conditions have been used for the proliferation ofJM cells. A maximal effect was obtained with 10 Ag offibrinogen per ml-a concentration 1/300th that normally found in plasma (Fig. 2) .
The mitogenic effect of fibrinogen was tested in a situation where fibrin could not be formed. Plasmin treatment progressively degrades the fibrinogen molecule producing two D fragments and one E fragment per molecule. Fragment D not only cannot form fibrin but even inhibits its formation (22) . Purified fragment D, but not fragment E, had a proliferative effect similar to that ofthe intact fibrinogen molecule (Fig. 2 ). In the culture conditions described in Fig. 2 , an optimal response was obtained for fragment D at 10 jug/ml (0.1 /LM). These results suggest that fibrin formation is not a prerequisite for the proliferative effect of fibrinogen.
Raji cell line. The Raji cell line contains mainly pre-B-cells but early B cells are also present (23) . The minimal medium used for JM did not sustain continuous growth of the Raji cells; however, it allowed growth for at least 10 divisions, whether cells were grown at low or at high cell densities. At low cell densities no residual growth was observed in IMD medium alone. Addition of transferrin allowed DNA synthesis and two karyokineses to occur. However, no cytokinesis took place because polykaryons were formed (Fig. 3) Fig. 4 ; they are quite similar to those obtained with JM (Fig. 2) .
Absence of Soluble Growth Factors in Fibrinogen Preparations. To eliminate the possibility that soluble low molecular weight growth factors might be contaminating the fibrinogen preparation, the supernatants obtained after fibrinogen clotting were tested for their ability to stimulate Raji cell proliferation. No stimulation was observed, regardless of the concentrations used (data not shown). Thrombin, at the concentration used, was neither inhibitory nor stimulatory for the growth of Raji cells. To ensure that fibrin did not trap possible growth factors during clotting, we mixed radiolabeled insulin with the fibrinogen solutions. After clotting and fibrin extraction, 81% of the radiolabeled insulin but only 2.7% of the fibrinogen proteins were found in the supernatant. The fibrinogen proteins in the supernatant approximated the amounts ofpeptides A and B released on clotting.
Effect of Fibrinogen on Growth in Nonminimal Defined Media. In addition to lymphoid cell lines, myeloid cell lines were studied for their proliferative responses to fibrinogen. T  TL  T  none  S  T  T  none  S  T  TL  TLI  T  TL  TL  TL  none  S  T  TI  TL  TLI  TI  none  S  L  LI  TL As the optimal cell density may vary with cells from one donor to another, three experiments were performed with cells from one normal donor. * Proliferative index of n-cell colonies in the presence of fibrinogen (10 Hg/ml) is calculated as follows.
Number of n-cell colonies with fibrinogen .X 100.
Number of n-cell colonies without fibrinogen fibrinogen. Eleven days later, cultures seeded at 5 x 104 cells per ml were dead. On the other hand, in cultures seeded at the higher concentrations, addition of fibrinogen increased the number of 20-30 cell colonies by a factor of4 and the number ofcolonies with more than 50 cells by a factor of20. In the presence of erythropoietin, fibrinogen was also found to increase the number and size of erythroid colonies (data not shown).
Long-term bone marrow cultures. The addition offibrinogen to a long-term serum-containing culture greatly reduced the time-associated decrease in the.production of colony-forming cells. Fig. 5 We observed that fibrinogen was active in vitro at concentrations -'1/300th that of the concentration found in plasma, and fragment D was less effective at 100 than 10 ,ug/ml. One possible explanation for these observations could be that the affinity ofthese molecules for certain cells are different in vitro and in vivo. In vivo, physiological mechanisms such as hemostatic controls could modify the interaction between cells and fibrinogen. For example, it has been shown that fibrinogen binds to platelets only when they are activated (14) .
The effect of fibrinogen also could be observed in the presence of a serum complement in primary human bone marrow cultures. Cell heterogeneity made the analysis of fibrinogen growth-stimulating activity on these cultures difficult. However, the fact that fibrinogen increased the number of larger colonies more than it did the number of smaller ones suggests that fibrinogen is more active on the most immature colonyforming cells. Another possibility would be that fibrinogen slows down differentiation processes, allowing more cell divisions before terminal differentiation. Recently Messner et al (25) have obtained improved results in mixed colony assays by replacing part of the serum with plasma. The presence of fibrinogen in plasma could explain the positive response obtained.
Further analysis is required to determine whether fibrinogen binds specifically to certain cells as has been reported for activated platelets (14) . Fibrinogen also could have a binding site for a growth factor. These molecules, present in serum or produced by certain cells, could be active only after binding to fibrinogen or its fragment D which could serve as a carrier protein.
